IL6 and congenital rubella syndrome: NKs seem to be good CAR drivers due to their specific innate characteristics and the absence of IL-6 secretion, which may reduce systemic toxicity by decreasing the risk of CRS; nevertheless, scant research has been published on treating PC, though the results of the few studies that have been conducted are encouraging.